Accelerating Asia’s digital GMP transformation with industry 4.0 technologies
Posted on March 31, 2022 by Lorenzo Sarasa
According to a report by IDC, the three most important trends that came to light because of the pandemic included:
- Global supply chain vulnerability needing to be addressed strategically
- Incentives needing to increase manufacturing footprints to meet global/regional demand
- Manufacturing of more pharmaceuticals moving locally to better serve home markets
Kenneth Tao (Client Service Executive & Associate Director at Cognizant) explores how all three trends can be addressed by advanced digital and analytical infrastructures. Find out more on how Tao envisages pharma’s journey to 4.0 transition here (pages 22-24).
Read the full article on pages 22-24:
Comments are closed.